3M India Limited Schedules Board Meeting on May 22, 2026 to Consider FY26 Audited Results and Dividend

3M India Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for May 22, 2026 (Friday), in compliance with Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued on May 17, 2026, by Pratap Rudra Bhuvanagiri, Company Secretary and Compliance Officer.

Board Meeting Agenda

The board meeting has been convened to consider and approve key corporate matters pertaining to the financial year ended March 31, 2026. The following items are on the agenda:

Agenda Item:	Details
Financial Results:	Audited Financial Results for the year ended March 31, 2026
Dividend:	Recommendation of Dividend, if any, for the financial year ended March 31, 2026
Other Matters:	Additional items as applicable

Trading Window Closure

In accordance with the Code of Conduct to Regulate, Monitor and Report Trading by Insiders, framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for 3M India Limited remains closed from April 1, 2026 to May 24, 2026, both days inclusive. This closure is a standard regulatory measure observed ahead of the disclosure of material financial information.

Company Details

Key details pertaining to the company and this regulatory filing are as follows:

Parameter:	Details
Registered Office:	Plot No 48-51, Electronics City, Bengaluru 560100
Corporate Office:	5th Floor Marksquare, 61, St Marks Road, Bengaluru 560001
CIN:	L31300KA1987PLC013543
Filing Date:	May 17, 2026
Board Meeting Date:	May 22, 2026

The intimation has been filed with both BSE Limited and the National Stock Exchange of India Limited. The company has also indicated that this intimation will be made available on its official website for public reference.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.70%	-0.84%	+1.07%	-11.51%	+7.48%	+26.59%

3M India Limited has provided formal intimation regarding the cessation of Rajiv Gupta as Country Business Leader - Healthcare Business and Senior Management Personnel, effective April 30, 2026. This development follows the company's earlier announcement on April 16, 2026, about leadership changes in its healthcare division.

Cessation Details

Rajiv Gupta has formally communicated his decision to step down from his current position, effective from the close of business hours on April 30, 2026. In his resignation letter addressed to the Managing Director, Gupta stated that he will be taking up a new role within the 3M Group, necessitating his cessation as Country Business Leader - Healthcare Business and consequently as Senior Management Personnel of the company.

Parameter	Details
Person:	Rajiv Gupta
Position:	Country Business Leader - Healthcare Business
Cessation Date:	April 30, 2026 (close of business hours)
Reason:	Transition to new role within 3M Group
Status:	Cessation as Senior Management Personnel

Leadership Transition Context

The cessation of Gupta follows the Board of Directors' approval of Jerry Daniel as the new Country Business Leader - Healthcare, effective May 1, 2026. Daniel, currently serving as Business Operations Leader - Transportation & Energy based in Pune, brings over a decade of experience within the 3M organization since 2013.

Regulatory Compliance

The intimation was made in compliance with Regulation 30 read with sub-para 7C of Para A of Part A Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal letter submitted by Rajiv Gupta has been enclosed as Annexure A to the regulatory filing.

The disclosure, dated April 23, 2026, was signed by Pratap Rudra Bhuvanagiri, Company Secretary & Compliance Officer, and communicated to both BSE Limited (Scrip Code: 523395) and National Stock Exchange of India Limited (Scrip Code: 3MINDIA). This communication serves as a continuation of the earlier disclosure dated April 16, 2026, regarding Gupta's transition.